Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

J Neurol. 2022 Nov;269(11):6152-6154. doi: 10.1007/s00415-022-11222-8. Epub 2022 Jun 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Myasthenia Gravis* / complications
  • Myasthenia Gravis* / drug therapy
  • Thymectomy

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab